New! Sign up for our free email newsletter.
Science News
from research organizations

Taking proton pump inhibitors not linked to higher dementia risk

Date:
November 21, 2017
Source:
American Geriatrics Society
Summary:
Scientists have concluded that developing dementia or Alzheimer's disease (the most common form of dementia) did not appear to be linked to taking proton pump inhibitors (PPIs).
Share:
FULL STORY

Proton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD). As of 2011, up to 1 in 5 older adults reported using a PPI. Although healthcare practitioners have long believed that PPIs are safe, recent studies have linked PPIs to potential risks, including fractures and kidney disease. Some studies also have linked PPIs to an increased risk for dementia among older adults. However, several experts have suggested that these studies may not correctly measure the connection.

In a new research article published in the Journal of the American Geriatrics Society, scientists were able to conclude that developing dementia or Alzheimer's disease (the most common form of dementia) did not appear to be linked to taking PPIs.

The researchers reviewed information from the Adult Changes in Thought (ACT) study, which included 3,484 adults aged 65 and older. Participants did not have dementia at the beginning of the study and were followed for an average of about 7.5 years.

Researchers tested participants for dementia at the beginning of the study and then every two years. Those who tested positive were given complete evaluations to measure their abilities to think and make decisions. Researchers gave the participants who were diagnosed with dementia follow-up tests to confirm the diagnosis.

Researchers used information from the ACT study to learn how many participants took PPIs and for how long. Overall, almost 24 percent of study participants developed dementia. Of these individuals, just 670 people developed possible or probable Alzheimer's disease. While other safety concerns with long-term PPI use exist, the researchers conluded that results from this study suggest that dementia is not linked to taking a PPI.


Story Source:

Materials provided by American Geriatrics Society. Note: Content may be edited for style and length.


Journal Reference:

  1. Shelly L. Gray, Rod L. Walker, Sascha Dublin, Onchee Yu, Erin J. Aiello Bowles, Melissa L. Anderson, Paul K. Crane, Eric B. Larson. Proton Pump Inhibitor Use and Dementia Risk: Prospective Population-Based Study. Journal of the American Geriatrics Society, 2017; DOI: 10.1111/jgs.15073

Cite This Page:

American Geriatrics Society. "Taking proton pump inhibitors not linked to higher dementia risk." ScienceDaily. ScienceDaily, 21 November 2017. <www.sciencedaily.com/releases/2017/11/171121141921.htm>.
American Geriatrics Society. (2017, November 21). Taking proton pump inhibitors not linked to higher dementia risk. ScienceDaily. Retrieved December 22, 2024 from www.sciencedaily.com/releases/2017/11/171121141921.htm
American Geriatrics Society. "Taking proton pump inhibitors not linked to higher dementia risk." ScienceDaily. www.sciencedaily.com/releases/2017/11/171121141921.htm (accessed December 22, 2024).

Explore More

from ScienceDaily

RELATED STORIES